Assignee
EVIVE BIOTECHNOLOGY SHANGHAI LTD
CN·3 granted patents·3 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
6 records- 0176US11654104B2Use of IL-22 dimer in manufacture of a medicament for intravenous administrationEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2019·Granted May 23, 2023·1 cites·19 claims
- 0271US2023301901A1Use of il-22 dimer in manufacture of a medicament for intravenous administrationEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2023·Application pending·0 cites
- 0366US11510966B2Use of IL-22 in treating necrotizing enterocolitisEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2017·Granted Nov 29, 2022·1 cites·21 claims
- 0455US2026053742A1Formulations comprising g-csf and uses thereofEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2023·Application pending·0 cites
- 0551US12527875B2Methods for treating graft versus host diseaseEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2021·Granted Jan 20, 2026·0 cites·20 claims
- 0651US2023079150A1Methods for prevention or treatment of virus-induced organ injury or failure with il-22 dimerEVIVE BIOTECHNOLOGY SHANGHAI LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVIVE BIOTECHNOLOGY SHANGHAI LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →